NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

The only trials I think NWBO will ever pay for in the future are those involving Direct (and even Direct might be getting a licensing deal with a BP).

Every DCVax-L trial in the future will be carried out by a partner who has a checkpoint inhibitor. There will be plenty of takers, but if we see just one partner for the combination trials they are in talks about, that partner will be the favorite for an exclusive agreement for use of DCVax-L with a checkpoint inhibitor.

I have always felt that Merck was the partner for GBM, since they pushed out Bristol Meyers for Merck. I could not imagine that Merck does not have a deal (or the framework in place in case of a successful trial) for exclusive use of DCVax-L in GBM before paying/sponsoring the current trial at UCLA.


JMHO